Author: R&D Team, CUIGUAI Flavoring
Published by: Guangdong Unique Flavor Co., Ltd.
Last Updated: Aug 25, 2026
WhatsApp & Telegram: +86 189 2926 7983
Email：info@cuiguai.com
Direct answer: GB 41700-2022 is China’s current mandatory national standard for electronic cigarettes. The official record shows publication on April 8, 2022 and implementation on October 1, 2022. Official policy interpretation states that atomization material must contain nicotine, products must not present a characterizing flavor other than tobacco, and the standard lists 101 permitted additives. Compliance is product-specific: manufacturers must use the authoritative Chinese text, applicable administrative measures, technical-review requirements, licensed channels, and current implementing rules—not an informal English summary alone.
For B2B flavor suppliers and device manufacturers, search intent is practical: Which rules apply? What evidence should a supplier provide? Does a positive-list ingredient automatically make a product compliant? How does China differ from the United States and European Union? This guide answers those questions without reproducing Annex A or making unsupported concentration claims. Regulations change, and qualified Chinese counsel or regulatory specialists should review any market decision.
GB Standard E-Liquid Compliance
The official national-standards platform identifies GB 41700-2022, Electronic Cigarette, as a current mandatory standard under the State Tobacco Monopoly Administration, with CCS X87 and ICS 65.160. It addresses devices, atomization material, emissions, test methods, labeling, and instructions. It should be read within China’s broader licensing, technical-review, transaction, and enforcement framework.
The official standard record lists April 8, 2022 as the publication date and October 1, 2022 as the implementation date. SAMR and the Standardization Administration issued the standard, and the State Tobacco Monopoly Administration is the competent and centralized department shown in the record. These primary-source facts are stronger than dates repeated by commercial summaries.
The accompanying official policy Q&A explains that the standard supports the regulatory framework established under China’s tobacco laws and the Administrative Measures for Electronic Cigarettes. After the transition, production and operation must follow the law, administrative measures, national standard, and supporting policies. A compliant ingredient list is therefore only one part of market access.
The standard covers electronic cigarettes and related product requirements; flavor suppliers operate upstream of the finished product. Their information can support an OEM’s review, but the finished-product manufacturer must control the complete formulation, device, emissions, labeling, technical review, and regulated transaction pathway. Responsibility cannot be outsourced to a flavor certificate.
Build a jurisdiction matrix before development. Identify whether the formulation is for China’s domestic market, export only, or a separate foreign-market variant. Do not assume that an export formulation can enter China or that a China-oriented formulation satisfies another jurisdiction. Keep product codes and records distinct to prevent accidental cross-use.
Official interpretation states that, after safety-risk assessment, experimental verification, and consultation, the standard lists 101 permitted additives in a white list. It also states that products should not present a characterizing flavor other than tobacco and that atomization material should contain nicotine. These points define the domestic-market formulation context more accurately than a claim that all listed additives may be used freely.
A supplier should map every intentionally added constituent to the authoritative Annex A entry and applicable condition. The map should use substance identity, Chinese name, CAS number where supplied, specification, source, and intended concentration. Ambiguous mixtures require composition disclosure or a justified method for resolving constituents.
Listing does not remove the need to assess purity, restricted use, analytical detectability, interactions, emissions, or the finished product. Nor does it authorize non-tobacco characterizing flavors. Teams should treat positive-list review as the first gate, followed by formula-level, device-level, and regulatory review.
Annex details should be checked directly against the current official Chinese standard and any controlling implementation documents. Do not copy quantitative limits from blogs without verifying substance identity, units, basis, and amendments. A misplaced decimal or confusion between concentrate and finished atomization material can invalidate the assessment.
English translations can support communication but are not the controlling legal text. Maintain a controlled copy of the source used, its retrieval date, reviewer, and interpretation notes. If a compound is unclear, escalate before formulation rather than rationalizing similarity to a listed food flavor.
The official Q&A says atomization material should contain nicotine and explains the policy basis for excluding nicotine-free products from domestic sale under the standard. The source text should be consulted for specifications, while licensing and technical-review rules determine how products move through the market.
The source article asserted tobacco extraction and minimum purity requirements. Such specifications must be checked against the official standard’s operative clauses before they appear in a formulation specification or customer declaration. Supplier identity, origin evidence, analytical purity, storage, and chain of custody should be controlled in the quality system.
Avoid broad statements that a particular nicotine source or salt automatically creates compliance. Acid components, impurities, concentration, package, and emissions remain relevant. If nicotine is outside the flavor supplier’s scope, state that boundary clearly in technical documents rather than implying certification of the complete e-liquid.
Official policy materials prohibit sale of electronic cigarettes that consumers can refill with atomization material. For supply planning, this means domestic products should be developed around the permitted product architecture and the authorized manufacturer-to-market pathway, not the open-bottle retail model common in some other markets.
Packaging and device design are not merely commercial choices. Leakage prevention, tamper resistance, material compatibility, dose delivery, and emissions under foreseeable operating conditions belong in the finished-product evidence package. A flavor concentrate specification cannot substitute for device testing.
A useful supplier file is traceable, version-controlled, and explicit about its limits. It helps the finished-product manufacturer reproduce the formula, evaluate listed substances, investigate signals, and prepare technical-review materials. It should not use vague phrases such as “GB compliant” without stating what was actually checked.
Maintain formula code and revision; component names and identifiers; supplier and lot; composition ranges appropriate to confidentiality arrangements; carrier system; specifications; certificates of analysis; safety data; origin and change-control status; and a signed regulatory review against the target market. For blends, identify constituents at the level needed for legal and toxicological assessment.
Distinguish intentionally added substances, carrier constituents, reaction products, impurities, and analytical artifacts. Establish reporting and decision rules before testing. If a supplier changes process, raw material, or site, assess whether identity, impurity profile, sensory output, or compliance mapping could change.
Chromatography and mass spectrometry can support identity and quantitation, but no single generic “GC-MS certificate” proves complete compliance. Method selection depends on volatility, polarity, matrix, target analytes, detection limits, standards, calibration, recovery, uncertainty, and sample preparation. Some constituents may require a different method.
Define the analytical question first: confirm target concentration, screen undeclared volatiles, verify nicotine purity, profile impurities, or characterize emissions. Validate or qualify the method for that purpose. Reports should state method, laboratory, sample and lot, date, results, units, detection or quantitation limits, and interpretation responsibility.
E-Liquid Analytical Testing
The three systems ask different legal questions. A useful comparison avoids calling one system simply “stricter,” because substance lists, product authorization, notification, nicotine limits, packaging, national restrictions, and enforcement operate differently. Always define the exact product and country.
China combines GB 41700-2022 with licensing, technical review, the national transaction platform, product restrictions, and enforcement under the tobacco regulatory system. The white list and tobacco-characterizing-flavor rule directly constrain domestic formulation. Evidence must connect ingredients to the finished product and authorized pathway.
For teams building a China file, the official standard record and policy Q&A are the starting points. Third-party commentary can help explain workflow but should not displace the primary text. Record the date of every regulatory check because status and implementing requirements may change.
FDA states that a PMTA for a new tobacco product must provide scientific data demonstrating that marketing would be appropriate for the protection of public health. FDA considers population-level risks and benefits, initiation and cessation behavior, and manufacturing methods, facilities, and controls. The 2021 final rule sets required content, format, review, and recordkeeping.
An ingredient list or China white-list match does not satisfy PMTA requirements. Applicants need product-specific evidence and must follow the current rule and guidance. A supplier can support identity, composition, manufacturing, and analytical sections, but only FDA can grant a marketing order. For related workflow context, see CUIGUAI’s vape flavoring risk-assessment model.
Article 20 of Directive 2014/40/EU governs electronic cigarettes and refill containers at EU level, including notification and product requirements. Member States implement and enforce the directive and may have additional restrictions. Therefore “EU compliant” is incomplete without the destination country and current national rules.
Do not characterize the EU framework as permission for any additive not explicitly banned. Manufacturers must assess ingredient safety and comply with notification, nicotine, volume, packaging, information, and national requirements applicable to the product. Regulatory review should be refreshed before launch or reformulation.
A disciplined sequence prevents sensory work from outrunning compliance. Each gate should have an owner, required inputs, decision record, and version. If the target market or product architecture changes, reopen affected gates rather than reusing the old conclusion.
Confirm domestic China versus export; device and closed-system architecture; intended adult user; tobacco character; nicotine scope; responsible licensees; and expected technical-review route. Document claims, label language, and channels. Stop if the commercial concept conflicts with a basic market restriction.
Create a regulatory basis sheet listing primary sources, edition, retrieval date, and reviewer. Separate legal requirements from internal policy and customer preferences. This prevents a commercial request from being mistaken for a regulatory obligation.
Map each component to the controlling standard and specification. Review concentration on the correct basis, formula totals, purity, prohibited or unlisted materials, carrier contributions, and possible impurities. Require a second-person check for identity, units, and calculations.
Use a market-specific formula code and lock it after approval. Any substitution, supplier change, or range expansion should trigger change control. Sensory optimization must remain inside the approved constituent framework; an attractive top note is not a justification for an unlisted substance.
Prepare prototypes under controlled conditions and evaluate physical stability, sensory consistency, package compatibility, and device performance. Design analytical work around the applicable standard and technical-review plan. Include blanks, controls, reference materials, and traceable samples.
The heated aerosol can differ from the liquid because temperature, power, coil, airflow, and matrix influence transfer and transformation. Product assessment therefore needs device-relevant conditions. Do not infer emissions compliance from liquid composition alone.
Assemble specifications, batch records, supplier approvals, analytical reports, stability evidence, change history, review approvals, and customer-facing declarations. Release only the exact reviewed formula and lot status. Define retention periods and escalation paths for deviations.
After launch, monitor complaints, analytical trends, supplier notices, regulatory changes, and product-review conditions. Reassess when new evidence, process change, device change, or market expansion affects the original rationale. Compliance is a maintained state, not a one-time certificate.
A buyer needs enough information to evaluate the concentrate in its own finished product. Confidentiality can be managed by agreements, controlled disclosure, or regulator-facing files, but it should not be used to conceal information necessary for safety and compliance.
Request product name and code, version, intended market, full or appropriately controlled constituent disclosure, lot-specific certificate of analysis, specifications, safety data, allergen or other declarations where relevant, manufacturing site, traceability, shelf life, storage, change-control commitment, and analytical scope.
Ask what “compliant” means in the document. Does it mean ingredients were screened against Annex A, concentrations were calculated, a batch was tested, or a finished product passed technical review? Precise wording prevents the customer from overextending a limited supplier conclusion.
Which analytes and matrices were covered? Were authentic standards used? What were calibration range, recovery, repeatability, and uncertainty? What are LOD and LOQ? Does the result apply to the concentrate, finished atomization material, or emissions? Was the method validated for that purpose?
Review unresolved peaks and unexpected results rather than focusing only on a pass label. Require laboratory competence appropriate to the work and preserve raw-data traceability under the applicable quality system. Analytical evidence is persuasive when it is reproducible and connected to a defined decision.
The answers below distinguish verified official facts from items that require product-specific review.
The official national-standard record lists publication on April 8, 2022 and implementation on October 1, 2022. It identifies the standard as current and mandatory. Always check the official platform for status before relying on a historical copy.
Official SAC policy interpretation says the standard lists 101 permitted additives in a white list. Use the authoritative Annex A text to confirm identity, conditions, and any quantitative requirement. Do not treat the count itself as a formulation approval.
Official policy interpretation says products should not present a characterizing flavor other than tobacco. A compound may appear on a permitted list for a technical purpose without authorizing a fruit-character product concept. Evaluate the complete sensory profile and current rules.
No. A fit-for-purpose report can support identity or quantitation, but compliance also depends on method scope, nonvolatile constituents, formulation calculations, impurities, device and emissions requirements, labeling, technical review, licensing, and market controls.
Possibly for selected ingredients, but never assume full multi-market compliance. China’s domestic flavor and product rules, EU Article 20 and national implementation, and FDA’s product-specific PMTA pathway differ. Build a jurisdiction matrix and obtain current specialist review.
A supplier can provide scoped evidence about its concentrate, ingredients, production, and testing. The responsible finished-product manufacturer must integrate that evidence with device, formula, emissions, packaging, labeling, and market-authorization requirements. Supplier statements should clearly define their scope.
GB Additive Review Framework
Controlled E-Liquid Manufacturing
Guangdong Unique Flavor Co., Ltd. supports B2B flavor discussions with market-specific formula identification, controlled documentation, and application testing. Any compliance statement is limited to its stated scope and does not replace finished-product legal review or government authorization.
Technical consultation and free sample requests:
Website: https://www.cuiguai.com
Email: info@cuiguai.com
Tel: +86 0769 88380789
WhatsApp & Telegram: +86 189 2926 7983
Relevant application starting points include the Tobacco Flavor product page and Lemon Tobacco Flavor product page; current product-development context can also be explored through the 2026 complex-dessert flavor forecast.
The business scope includes licensed projects: food additive production. General projects: sales of food additives; manufacturing of daily chemical products; sales of daily chemical products; technical services, technology development, technical consultation, technology exchange, technology transfer, and technology promotion; biological feed research and development; industrial enzyme preparation research and development; cosmetics wholesale; domestic trading agency; sales of sanitary products and disposable medical supplies; retail of kitchenware, sanitary ware and daily sundries; sales of daily necessities; food sales (only sales of pre-packaged food).
Copyright ©Guangdong Unique Flavor Co., Ltd.All Rights Reserved. Privacy Policy Return and Exchange Policy
